Works matching IS 15228517 AND DT 2017 AND VI 19 AND IP 8
Results: 17
Highlights from the Literature.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 8, p. 1021, doi. 10.1093/neuonc/nox114
- Publication type:
- Article
Prophylactic cranial irradiation in patients with extensive-stage small cell lung cancer.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 8, p. 1015, doi. 10.1093/neuonc/nox113
- By:
- Publication type:
- Article
A search for the "Goldilocks zone" with regard to the optimal duration of adjuvant temozolomide in patients with glioblastoma.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 8, p. 1019, doi. 10.1093/neuonc/nox046
- By:
- Publication type:
- Article
The radiosensitivity of brain metastases based upon primary histology utilizing a multigene index of tumor radiosensitivity.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 8, p. 1145, doi. 10.1093/neuonc/nox043
- By:
- Publication type:
- Article
Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 8, p. 1047, doi. 10.1093/neuonc/nox026
- By:
- Publication type:
- Article
Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 8, p. 1119, doi. 10.1093/neuonc/nox025
- By:
- Publication type:
- Article
Lessons learned from diffuse intrinsic pontine glioma: how a terrible disease forced us to think better.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 8, p. 1017, doi. 10.1093/neuonc/nox022
- By:
- Publication type:
- Article
Diffuse intrinsic pontine gliomas--current management and new biologic insights. Is there a glimmer of hope?
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 8, p. 1025, doi. 10.1093/neuonc/nox021
- By:
- Publication type:
- Article
Sleep disturbance of adults with a brain tumor and their family caregivers: a systematic review.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 8, p. 1035, doi. 10.1093/neuonc/nox019
- By:
- Publication type:
- Article
Frequent AKT1<sup>E17K</sup> mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 8, p. 1088, doi. 10.1093/neuonc/nox018
- By:
- Publication type:
- Article
Glioblastoma stem cell differentiation into endothelial cells evidenced through live-cell imaging.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 8, p. 1109, doi. 10.1093/neuonc/nox016
- By:
- Publication type:
- Article
Evaluating the significance of density, localization, and PD-1/PD-L1 immunopositivity of mononuclear cells in the clinical course of lung adenocarcinoma patients with brain metastasis.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 8, p. 1058, doi. 10.1093/neuonc/now309
- By:
- Publication type:
- Article
The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 8, p. 1097, doi. 10.1093/neuonc/now304
- By:
- Publication type:
- Article
Repositioning disulfiram as a radiosensitizer against atypical teratoid/rhabdoid tumor.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 8, p. 1079, doi. 10.1093/neuonc/now300
- By:
- Publication type:
- Article
The transcription factor Olig2 is important for the biology of diffuse intrinsic pontine gliomas.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 8, p. 1068, doi. 10.1093/neuonc/now299
- By:
- Publication type:
- Article
A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 8, p. 1135, doi. 10.1093/neuonc/now282
- By:
- Publication type:
- Article
Characteristics of H3 K27M-mutant gliomas in adults.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 8, p. 1127, doi. 10.1093/neuonc/now274
- By:
- Publication type:
- Article